PTC Therapeutics, Inc. Reports Second Quarter 2013 Financial and Corporate Results

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH PLAINFIELD, N.J., Aug. 12, 2013 /PRNewswire/ -- PTC Therapeutics, Inc. PTCT, a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes, today announced financial and corporate results for the quarter ended June 30, 2013.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC